Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis
about
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@en
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@nl
type
label
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@en
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@nl
prefLabel
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@en
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@nl
P2093
P2860
P50
P921
P1433
P1476
Active-site mTOR inhibitors au ...... dysregulated eIF4E/4E-BP axis
@en
P2093
Adrian Pelin
Chadi Zakaria
Dana Pearl
Huy-Dung Hoang
Jaclyn Hearnden
Jian-Jun Jia
John Cameron Bell
Margaret Watson
Nahum Sonenberg
Polen Sean
P2860
P304
P356
10.1371/JOURNAL.PPAT.1007264
P407
P50
P577
2018-08-23T00:00:00Z